CARACCIOLO, Daniele
 Distribuzione geografica
Continente #
NA - Nord America 137
AS - Asia 91
SA - Sud America 34
EU - Europa 25
AF - Africa 5
Totale 292
Nazione #
US - Stati Uniti d'America 128
SG - Singapore 29
BR - Brasile 21
VN - Vietnam 19
CN - Cina 15
HK - Hong Kong 10
IT - Italia 10
AR - Argentina 6
MX - Messico 6
FR - Francia 5
DE - Germania 4
IN - India 3
BD - Bangladesh 2
CA - Canada 2
GB - Regno Unito 2
IQ - Iraq 2
KR - Corea 2
MA - Marocco 2
PE - Perù 2
PK - Pakistan 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
FI - Finlandia 1
ID - Indonesia 1
KG - Kirghizistan 1
NL - Olanda 1
OM - Oman 1
PY - Paraguay 1
SA - Arabia Saudita 1
TR - Turchia 1
UA - Ucraina 1
UY - Uruguay 1
VE - Venezuela 1
Totale 292
Città #
Dallas 111
Singapore 14
Hong Kong 10
Ho Chi Minh City 7
San Jose 7
Hanoi 6
Beijing 5
Mexico City 3
Ashburn 2
Catania 2
Da Nang 2
Hefei 2
Lauterbourg 2
Los Angeles 2
Montreal 2
Rabat 2
Rio de Janeiro 2
Seoul 2
Tashkent 2
Abreu e Lima 1
Agudo 1
Ankara 1
Araras 1
Baghdad 1
Bihać 1
Biên Hòa 1
Bonito 1
Bragança Paulista 1
Brasília 1
Brits 1
Campinas 1
Cantanhede 1
Caracas 1
Cariacica 1
Charlotte 1
Chicago 1
Dhaka 1
Duhok 1
Frankfurt am Main 1
General Pico 1
Haiphong 1
Helsinki 1
Huế 1
Iaçu 1
Ituzaingó 1
Jardim 1
Jiutepec 1
Karachi 1
Krugersdorp 1
Larkana 1
London 1
Malnate 1
Mar de Ajó 1
Maringá 1
Medellín 1
Milan 1
Monclova 1
Montevideo 1
Mumbai 1
Nazca 1
New Malden 1
New York 1
Nova Olinda do Maranhão 1
Olaeta 1
Petrópolis 1
Pune 1
Puno 1
Quilmes 1
Quito 1
Rende 1
Riyadh 1
Rome 1
Salalah 1
San José 1
San Pedro 1
Santa Clara 1
Senhor do Bonfim 1
Shanghai 1
Surabaya 1
São Bernardo do Campo 1
São Gonçalo 1
Taubaté 1
Thái Bình 1
Uberlândia 1
Villa Ballester 1
Totale 251
Nome #
CD19 CAR-T Outcomes in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Cohort Study from the Calabria Referral Center in Southern Italy 163
Relapsed/Refractory Follicular Lymphoma: Current Advances and Emerging Perspectives 86
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real‐World Study 34
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 13
Totale 296
Categoria #
all - tutte 724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202525 0 0 0 0 0 0 0 10 10 1 1 3
2025/2026271 8 6 125 14 25 14 26 12 22 19 0 0
Totale 296